Miller Wealth Advisors’s Pfizer PFE Stock Holding History

Miller Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41K	Hold	100	–	–	﹤0.01%	102
2026 Q1	$2.81K	Hold	100	–	–	﹤0.01%	95
2025 Q4	$2.49K	Hold	100	–	–	﹤0.01%	104
2025 Q3	$2.55K	Hold	100	–	–	﹤0.01%	94
2025 Q2	$2.42K	Hold	100	–	–	﹤0.01%	85
2025 Q1	$2.53K	Hold	100	–	–	﹤0.01%	80
2024 Q4	$2.65K	Hold	100	–	–	﹤0.01%	74
2024 Q3	$2.93K	Hold	100	–	–	﹤0.01%	71
2024 Q2	$2.8K	Hold	100	–	–	﹤0.01%	69
2024 Q1	$2.77K	Hold	100	–	–	﹤0.01%	69
2023 Q4	$2.88K	Hold	100	–	–	﹤0.01%	67
2023 Q3	$3.32K	Hold	100	–	–	﹤0.01%	63
2023 Q2	$3.67K	Buy	+100	New	+$3.89K	﹤0.01%	62
2023 Q1	–	Sell	-100	Closed	-$4.32K	–	72
2022 Q4	$5K	Hold	100	–	–	﹤0.01%	61
2022 Q3	$5K	Hold	100	–	–	﹤0.01%	74
2022 Q2	$5K	Hold	100	–	–	﹤0.01%	66
2022 Q1	$5K	Hold	100	–	–	﹤0.01%	73
2021 Q4	$6K	Buy	+100	New	+$4.96K	﹤0.01%	70

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Miller Wealth Advisors's PFE Position: Q2 2026 in Review

Miller Wealth Advisors held its Pfizer (PFE) position steady in Q2 2026 at 100 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #102.

Miller Wealth Advisors first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $6K in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Miller Wealth Advisors held 100 shares of Pfizer worth $2.41K as of Q2 2026.
Miller Wealth Advisors left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Miller Wealth Advisors's portfolio in Q2 2026, its #102 holding.
Miller Wealth Advisors first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
Miller Wealth Advisors's Pfizer position peaked at $6K in Q4 2021.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.